Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 271

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 271
---
 Merger Agreement or the Merger and (iii) against any acquisition proposal involving a third party. The Tvardi Support Agreements terminated automatically upon the effective time of the Merger. Lock-Up Agreements Concurrently with the execution of the Merger Agreement, certain executive officers, directors and stockholders of Legacy Tvardi entered into lock-up agreements (the “Lock-Up Agreements”), pursuant to which such persons accepted certain restrictions on transfers of the shares of our common stock held by such persons for the 180-day period following the effective time of the Merger. Convertible Notes In multiple closings to be held between December 5, 2024 and December 31, 2024, Legacy Tvardi issued and sold Convertible Notes in an aggregate amount of $28,297,679. The Convertible Notes accrued simple interest at 8% per annum and had a maturity date of December 31, 2026. Upon the closing of the Merger, the outstanding principal balance of such Convertible Notes and all unpaid accrued interest automatically converted into shares of our common stock, at a conversion price equal to 80% of the implied valuation of the combined company in the Merger. The following table summarizes the Convertible Notes purchased by holders of more than 5% of Legacy Tvardi’s capital stock and entities affiliated with its executive officers and members of its board of directors.

| ​                                             | ​ |           ​ |
| ​                                             | ​ |   Aggregate |
| ​                                             | ​ |   Principal |
| ​                                             | ​ |      Amount |
| ​                                             | ​ |      of the |
| ​                                             | ​ | Convertible |
| ​                                             | ​ |       Notes |
| Participants(1)                               |   |          -$ |
| Entities affiliates with Slate Path(2)        | ​ |   2,000,000 |
| BioMatrix Partners Ltd.(3)                    | ​ |   1,000,000 |
| Firepit Partners, LP (4)                      | ​ |     250,000 |
| Entities affiliated with Solas BioVentures(5) | ​ |  13,375,000 |

| (1) | Additional details regarding these stockholders or their affiliates and their equity holdings are included in this prospectus under the section titled “Principal Securityholders.” |

| (2) | Consisted of (i) $1,768,000 in an aggregate principal amount of Convertible Notes purchased by Slate Path Master Fund LP, which